[1]
P. Bossi and L. Lorini, “Treatment of Cutaneous Squamous Cell Carcinoma with Immune Checkpoint Inhibitors in Special Populations”, Dermatol Pract Concept, vol. 11, no. S2, p. e2021170S, Nov. 2021, doi: 10.5826/dpc.11S2a170S.